Patrycja Nowak-Sliwinska

Associate professor in Molecular Pharmacology

University of Geneva

Switzerland

Research Interests

Explore related searches

Professors in Switzerland Professors in Immunology Immunology professors in Switzerland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (8)

Pierre-Marie Allard

University of Geneva

SWITZERLAND

View details

Thomas McKee

Professor

University of Geneva

SWITZERLAND

View details

Lionel Alexandre Voirol

Ph.D. Candidate and Research & Teaching Assistant

University of Geneva

SWITZERLAND

View details

Didier Picard

Université de Genève

SWITZERLAND

View details

Thibaud Koessler

University of Geneva

SWITZERLAND

View details

David Skurnik

Full Professor of Medicine

Université Paris Cité

FRANCE

View details

Arjan Griffioen

Professor of Experimental Oncology and Angiogenesis

VU medisch centrum

NETHERLANDS

View details

Patrick Meraldi

University of Geneva

SWITZERLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Patrycja Nowak-Sliwinska

Research Interests

Explore related searches

Contact this professor

Articles (10)

Proinflammatory activity of VEGF-targeted treatment through reversal of tumor endothelial cell anergy

Platform combining statistical modeling and patient-derived organoids to facilitate personalized treatment of colorectal carcinoma

Network-informed discovery of multidrug combinations for ERα+/HER2-/PI3Kα-mutant breast cancer

FOLFOXIRI Resistance Induction and Characterization in Human Colorectal Cancer Cells

Extracellular vimentin mimics VEGF and is a target for anti-angiogenic immunotherapy

COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects

Drug Repurposing to Identify a Synergistic High-Order Drug Combination to Treat Sunitinib-Resistant Renal Cell Carcinoma

Anti-angiogenic agents — overcoming tumour endothelial cell anergy and improving immunotherapy outcomes

Molecular and Functional Analysis of Sunitinib-Resistance Induction in Human Renal Cell Carcinoma Cells

Forcing dividing cancer cells to die; low‐dose drug combinations to prevent spindle pole clustering

Collaborators (8)

Pierre-Marie Allard

Thomas McKee

Lionel Alexandre Voirol

Didier Picard

Thibaud Koessler

David Skurnik

Arjan Griffioen

Patrick Meraldi

Make your next move.